Related references
Note: Only part of the references are listed.EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer
Arijit Mal et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Decoding molecular interplay between RUNX1 and FOXO3a underlying the pulsatile IGF1R expression during acquirement of chemoresistance
Ajit C. Dhadve et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
The Role of Cancer Stem Cells in Radiation Resistance
Christoph Reinhold Arnold et al.
FRONTIERS IN ONCOLOGY (2020)
Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1
Yawei Zhao et al.
BRITISH JOURNAL OF CANCER (2020)
Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas
Valya Ramakrishnan et al.
EBIOMEDICINE (2020)
Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1
Wee S. Teo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Inhibition of RUNX1 promotes cisplatin-induced apoptosis in ovarian cancer cells
Li Xiao et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation
Songsong Liu et al.
GENOMICS (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer
Qingyuan Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
被撤回的出版物: Radiation-induced glucocorticoid receptor promotes CD44+prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling (Retracted article. See vol. 100, pg. 149, 2022)
Feng Chen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells
Yoshihide Mitsuda et al.
SCIENTIFIC REPORTS (2018)
Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence
Allison L. Boyd et al.
CANCER CELL (2018)
Runx1-Stat3 signaling regulates the epithelial stem cells in continuously growing incisors
Safiye E. Sarper et al.
SCIENTIFIC REPORTS (2018)
IL-6 mediates platinum -induced enrichment of ovarian cancer stem cells
Yinu Wang et al.
JCI INSIGHT (2018)
Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop
Bhushan Thakur et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
RUNX1 promote invasiveness in pancreatic ductal adenocarcinoma through regulating miR-93
Yin Cheng et al.
ONCOTARGET (2017)
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
Haiquan Lu et al.
CELL REPORTS (2017)
The Id-protein family in developmental and cancer-associated pathways
Cornelia Roschger et al.
CELL COMMUNICATION AND SIGNALING (2017)
Cancer stem cells and chemoresistance: The smartest survives the raid
Jihe Zhao
PHARMACOLOGY & THERAPEUTICS (2016)
An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population
Ram K. Singh et al.
SCIENTIFIC REPORTS (2016)
Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells
Dae Kyoung Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Differential activation of NF-kappa B signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells
Snehal M. Gaikwad et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
IGF-1R inhibition potentiates cytotoxic effects of chemotherapeutic agents in early stages of chemoresistant ovarian cancer cells
Ram K. Singh et al.
CANCER LETTERS (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
MicroRNA-302b Suppresses Human Epithelial Ovarian Cancer Cell Growth by Targeting RUNX1
Tingting Ge et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Cancer stem cells and radioresistance
Kiera Rycaj et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2014)
Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
Jianqun Liao et al.
PLOS ONE (2014)
Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
Nicola Ferrari et al.
PLOS ONE (2014)
Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population
Rachel Eyre et al.
TUMOR BIOLOGY (2014)
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion
Mamadou Keita et al.
CELL CYCLE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Mechanisms of chemoresistance in cancer stem cells
Lissa Nurrul Abdullah et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2013)
Aclinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia
Jonathan M. Gerber et al.
BLOOD (2012)
Self-Renewal Does Not Predict Tumor Growth Potential in Mouse Models of High-Grade Glioma
Lindy E. Barrett et al.
CANCER CELL (2012)
ID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21
Catherine A. O'Brien et al.
CANCER CELL (2012)
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells
C. M. Tate et al.
CELL DEATH AND DIFFERENTIATION (2012)
Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer
Cornelia Johanna Franziska Scheitz et al.
EMBO JOURNAL (2012)
The developing cancer stem-cell model: clinical challenges and opportunities
Louis Vermeulen et al.
LANCET ONCOLOGY (2012)
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction
Lea Cunningham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Radiation-Induced Reprogramming of Breast Cancer Cells
Chann Lagadec et al.
STEM CELLS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma
Jesus Planaguma et al.
HUMAN PATHOLOGY (2011)
Runx1 Directly Promotes Proliferation of Hair Follicle Stem Cells and Epithelial Tumor Formation in Mouse Skin
Charlene S. L. Hoi et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment
Chann Lagadec et al.
BREAST CANCER RESEARCH (2010)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
Selective Enrichment of Hepatocellular Cancer Stem Cells by Chemotherapy
S. Tan et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Scott J. Dylla et al.
PLOS ONE (2008)
Side population analysis using a violet-excited cell-permeable DNA binding dye
William G. Telford et al.
STEM CELLS (2007)
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation
Julie B. Sneddon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A side order of stem cells: The SP phenotype
GA Challen et al.
STEM CELLS (2006)
High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival
A van Rhenen et al.
CLINICAL CANCER RESEARCH (2005)
Flow cytometry-based approach to ABCG2 function suggests that the transporter differentially handles the influx and efflux of drugs
M García-Escarp et al.
CYTOMETRY PART A (2004)
Share Paper
